How Novo Nordisk, Columbia University and AWS collaborated to create OpenFold3

The article details how Novo Nordisk, Columbia University, and AWS collaborated to create OpenFold3, an advanced protein structure prediction model using AWS cloud services. The project addressed three key challenges:

• Creating a lean Research Collaboration Platform (RCP) with secure, flexible research infrastructure
• Optimizing Multiple Sequence Alignment (MSA) generation using AWS Graviton processors, reducing runtime by 50% and costs by 55%
• Implementing cost-effective AI/ML training using EC2 Capacity Blocks and Spot Instances across 256 GPUs

The collaboration successfully developed OpenFold3, a breakthrough in protein structure prediction that can accelerate drug discovery and therapeutic development by quickly and accurately predicting protein structures using AI and cloud computing.